Sign in
Taking people in United StatesNo phase

Capella Scientia Development Study

Key facts

Who runs it
Alcon Research
Where
Salt Lake City, United StatesSee the siteAlso in 3 other countries, 4 sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
30 Jul 2025
Expected to end
May 2027
Type of study
Observational, 4 groups
Treatments tested
  • Unity DX and SMARTCataract DX (SCDX) Biometer
  • IOLMaster 700 Biometer
  • Argos with Alcon Image Guidance Biometer
Record updated
30 October 2026

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Able to understand and sign an IRB/IEC approved consent form
  • Willing and able to attend study visit(s) as required by the protocol
  • Consenting age at the jurisdiction of study site
  • Other group-specific, protocol required inclusion criteria may apply

Who cannot take part

  • Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment
  • Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study
  • Women of child-bearing potential
  • Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus)
  • Unclear optical media preventing data capture from all devices in the study
  • Other group-specific, protocol required exclusion criteria may apply

This trial is currently available in United States.

Also in 3 other countries, 4 sites

  • The Eye Institute of UtahSalt Lake City, United StatesTaking people

About the trial

What the trial wants to find out

This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.

The 4 groups in the trial

  • Group 1

    Subjects/eyes previously implanted with an Alcon monofocal or multifocal presbyopia correcting IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer

  • Group 2

    Subjects/eyes with planned implantation of an Alcon monofocal or monofocal toric IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer

  • Group 3

    Subjects/eyes with with prior refractive surgery such as LASIK or PRK and planned implantation of an Alcon monofocal or monofocal toric IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer

  • Group 4

    Subjects/eyes with keratoconus, a progressive cornea disorder. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.

    Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Capella Scientia (SCDX) Development Study
Record updated
30 October 2026